Sage Therapeutics Inc. buy klostergang
Start price
24.11.18
/
50%
€102.23
Target price
04.11.21
€95.00
Performance (%)
-55.47%
End price
17.06.21
€45.52
Summary
This prediction ended on 17.06.21 with a price of €45.52. Massive losses of -55.47% were the result for the BUY prediction by klostergang. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Sage Therapeutics Inc. | -6.913% | -6.913% | -69.951% | -79.398% |
iShares Core DAX® | 0.476% | -0.039% | 13.342% | 17.330% |
iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% | 50.534% |
iShares Nikkei 225® | 1.300% | -2.135% | 19.861% | 4.937% |
iShares S&P 500 | 0.829% | 0.193% | 29.756% | 43.432% |
Comments by klostergang for this prediction
In the thread Sage Therapeutics Inc. diskutieren
klostergang stimmt dem Sentiment von 'Buy' zu
FDA advisors voted 18-0 that Zulresso (brexanolone) is effective for treatment of postpartum depression despite some reservations about the safety of home infusion.
An FDA decision is expected by December 19.
Update
: The vote was 17-1 that the drug's benefits outweigh the risks.
Kursziel geändert auf 95,0
Stopped prediction by klostergang for Sage Therapeutics Inc.
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€76.06
09.06.15
09.06.15
€75.00
09.06.15
09.06.15
0.00%
09.06.15
09.06.15